IL18 and diabetes mellitus: Moreover, in another animal model of diabetes, short-term prophylactic treatment with inhibitors of IL-18 (IL-18Bp-Fc-fusion molecule) significantly protected animals from developing overt diabetes, further strengthening the evidence suggesting the role of IL-18 in T1D (156).